Company Description
biote Corp. operates in practice-building business within the hormone optimization space.
It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients.
The company was founded in 2012 and is headquartered in Irving, Texas.
| Country | United States |
| Founded | 2012 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 223 |
| CEO | Robert Peterson |
Contact Details
Address: 1875 W. Walnut Hill Ln #100 Irving, Texas 75038 United States | |
| Phone | 844 604 1246 |
| Website | biote.com |
Stock Details
| Ticker Symbol | BTMD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1819253 |
| CUSIP Number | 090683103 |
| ISIN Number | US0906831039 |
| Employer ID | 85-1791125 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Marc D. Beer | Executive Chairman |
| John J. Olsen | Chief Information Officer |
| Dan Monico | General Counsel |
| Joel Pickering | Chief Marketing Officer |
| Richard Kevin Key | Chief Digital Officer |
| Jade Beutler | Head of Nutraceuticals |
| Joey Lopes | SVice President of Strategy and Commercial Operations |
| Dr. Komal Bajaj M.D., M.S. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 27, 2026 | SCHEDULE 13G/A | Filing |
| Jun 17, 2026 | 8-K/A | [Amend] Current report |
| Jun 2, 2026 | 8-K | Current Report |
| May 18, 2026 | 8-K | Current Report |
| May 13, 2026 | SCHEDULE 13G/A | Filing |
| May 11, 2026 | 10-Q | Quarterly Report |
| May 6, 2026 | 8-K | Current Report |
| Apr 14, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Apr 3, 2026 | 8-K | Current Report |
| Apr 2, 2026 | ARS | Filing |